Tafalla M, Sanchez-Moreno J, Diez T, Vieta E
Medical Department, AstraZeneca, Madrid, Spain.
J Affect Disord. 2009 Apr;114(1-3):299-304. doi: 10.1016/j.jad.2008.06.025. Epub 2008 Aug 13.
Bipolar spectrum disorders often go unrecognised and undiagnosed or misdiagnosed. One of the underlying reasons is the poor recognition of bipolar disorder among patients presenting depressive episodes. The specific aim of this study was to estimate the Mood Disorder Questionnaire (MDQ) rate of positive screens for bipolar disorder in a Spanish sample of outpatients with a current major depressive episode and compare it with their current psychiatric diagnosis. The study was designed to address this specific question.
971 consecutively outpatients with a current DSM-IV TR diagnosis of a major depressive episode entered this cross-sectional study. Study measures included sociodemographic and clinical data, Clinical Global Impression of Severity of Illness Scale (CGI-S), Hamilton Depression Scale (HAMD) and MDQ.
905 patients fulfilled criteria to be included in the analysis. All of them presented with a current major depressive episode. 74.3% (n=671) of the patients had received a diagnosis of unipolar depression and 25.7% (n=232) of bipolar disorder by a psychiatrist. Using a MDQ of 7-or-more-item threshold, the global positive screen rate for bipolar disorder was 41.3% (n=373). From the 671 patients with previous unipolar depression diagnosis, 161 (24%) screened positive for bipolar disorder with MDQ, whereas in 232 patients diagnosed of bipolar disorder, 212 (91.4%) screened positive for bipolar disorder.
The MDQ showed a positive screen rate for bipolar disorder in 24% of patients with a previous diagnosis of unipolar disorder and a current major depressive episode. Screening tools like MDQ could contribute to increase detection of bipolar disorder in patients with depression. Early diagnosis of bipolar disorder may have important clinical and therapeutic implications in order to improve the illness course and the long-term functional outcome.
双相谱系障碍常常未被识别、未得到诊断或被误诊。根本原因之一是在出现抑郁发作的患者中对双相情感障碍的识别不足。本研究的具体目的是估计在西班牙患有当前重度抑郁发作的门诊患者样本中双相情感障碍的心境障碍问卷(MDQ)阳性筛查率,并将其与他们当前的精神科诊断进行比较。该研究旨在解决这一具体问题。
971名连续的门诊患者,目前依据《精神疾病诊断与统计手册》第四版修订版(DSM-IV TR)诊断为重度抑郁发作,进入了这项横断面研究。研究措施包括社会人口统计学和临床数据、临床总体印象疾病严重程度量表(CGI-S)、汉密尔顿抑郁量表(HAMD)和MDQ。
905名患者符合纳入分析的标准。他们均患有当前重度抑郁发作。74.3%(n = 671)的患者被精神科医生诊断为单相抑郁,25.7%(n = 232)被诊断为双相情感障碍。使用MDQ七项及以上条目阈值,双相情感障碍的总体阳性筛查率为41.3%(n = 373)。在671名先前诊断为单相抑郁的患者中,161名(24%)MDQ筛查双相情感障碍呈阳性,而在232名诊断为双相情感障碍的患者中,212名(91.4%)MDQ筛查双相情感障碍呈阳性。
MDQ显示,在先前诊断为单相障碍且目前患有重度抑郁发作的患者中,24%的患者双相情感障碍筛查呈阳性。像MDQ这样的筛查工具可能有助于提高对抑郁症患者双相情感障碍的检出率。双相情感障碍的早期诊断可能对改善病程和长期功能结局具有重要的临床和治疗意义。